Proteomics

Dataset Information

0

Mesenchymal Stromal Cells: What are the secrets of their secretome?

ABSTRACT: Multipotent Mesenchymal Stromal Cells (MSCs) are multipotent adult cells that can be isolated from different tissues. The current hypothesis supports that the main MSCs action mechanism relates to its paracrine activity, creating a microenvironment with trophic signals. However, preclinical studies with different sources of MSCs and different animal models have shown conflicting results. Therefore, the evaluation of these cells secretome content is of great interest. Here we analyzed the secreted proteins of MSCs, isolated from 3 different sources (adipose tissue, uterine tubes and skeletal muscle), obtained from 5 different donors. Following MSCs characterization, proteins secreted in serum-free conditions (conditioned media, CM) were analyzed by mass-spectrometry-based quantitative proteomics.

INSTRUMENT(S): Q Exactive

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Whole Body, Mesenchymal Cell

SUBMITTER: Amanda Assoni  

LAB HEAD: Mayana Zatz

PROVIDER: PXD003978 | Pride | 2016-12-09

REPOSITORIES: Pride

Json Xml

Dataset's files

Source:
Action DRS
AFMZ01F-14_150116082700.raw Raw
AFMZ01F-15_150116104528.raw Raw
AFMZ01F-16.raw Raw
AFMZ01F-16_150116152128.raw Raw
AFMZ01F-17.raw Raw
Items per page:
1 - 5 of 51
altmetric image

Publications

Different Donors Mesenchymal Stromal Cells Secretomes Reveal Heterogeneous Profile of Relevance for Therapeutic Use.

Assoni Amanda A   Coatti Giuliana G   Valadares Marcos C MC   Beccari Melinda M   Gomes Juliana J   Pelatti Mayra M   Mitne-Neto Miguel M   Carvalho Valdemir M VM   Zatz Mayana M  

Stem cells and development 20161020 3

Duchenne muscular dystrophy (DMD) is a lethal X-linked disorder caused by null mutations in the dystrophin gene. Although the primary defect is the deficiency of muscle dystrophin, secondary events, including chronic inflammation, fibrosis, and muscle regeneration failure are thought to actively contribute to disease progression. Despite several advances, there is still no effective therapy for DMD. Therefore, the potential regenerative capacities, and immune-privileged properties of mesenchymal  ...[more]

Similar Datasets

Proteomics PRODUCT CHARACTERIZATION AND PRECLINICAL SAFETY OF UMBILICAL CORD MESENCHYMAL STROMAL CELL-DERIVED SMALL EXTRACELLULAR VESICLES
2024-05-04 | PXD038850 | Pride
Proteomics hMADS cells secretome identification LC/MS/MS
2021-12-01 | PXD029335 | Pride
Proteomics Integrative transcriptomic and proteomic analysis show circulating osteoprogenitors to have a mixed immune and mesenchymal progenitor function in humans
2024-10-17 | PXD035803 | Pride
Proteomics Osteogenic human MSC-derived extracellular vesicles regulate MSC activity and osteogenic differentiation and promote bone regeneration in a rat calvarial defect model
2024-01-10 | PXD043335 | Pride
Transcriptomics Human Multipotent Stromal Cells: Passage 3 vs. Passage 5 vs. Passage 7
2014-04-01 | E-GEOD-56362 | biostudies-arrayexpress
Proteomics Integrative analysis of mesenchymal stromal cell conversion by breast cancer secretomes in blank slate 3D microenvironments
2019-05-27 | PXD010467 | Pride
Transcriptomics scRNA-seq of Multi-lineage differentiating Stress Enduring (Muse) cell and non-Muse cells isolated from bone marrow-derived mesenchymal stem cells
2022-10-26 | E-MTAB-10854 | biostudies-arrayexpress
Proteomics Neuroprotective properties of Mesenchymal Stromal Cell–Derived Extracellular Vesicles in Models of Acute Brain Pathology
2022-10-14 | PXD027581 | Pride
Transcriptomics Transcription profiling of mesenchymal stem cells exposed to CM from tumor cells or bone marrow
2006-05-30 | E-MEXP-532 | biostudies-arrayexpress
Proteomics The Secretome of Human Neonatal Mesenchymal Stem Cells Modulates Doxorubicin-induced Cytotoxicity: Impact in Non-tumour Cells
2022-02-17 | PXD029795 | Pride